Thirty five classes of solutions of the quantum time-dependent two-state problem in terms of the general Heun functions
- 期刊名称The European Physical Journal D
- 作者Ishkhanyan, Artur M.; Shahverdyan, Tigran A.; Ishkhanyan, Tigran A.
- 卷第69卷
- 期第1期
- 印刷ISSN1434-6060
- 电子ISSN1434-6079
- 文件大小1336.64KB
- 发表时间2015-1
- DOI10.1140/epjd/e2014-50386-9
Cryptococcal disease in HIV infection: treatment and maintenance&NA;, · AIDS · 1995
Cryptococcal disease in HIV infection: treatment and maintenance&NA;, · AIDS · 1995
Complicated and Protracted Cryptococcal Disease in HIV-infected ChildrenHassan, Haseena; Cotton, Mark F.; Rabie, Helena · The Pediatric Infectious Disease Journal · 2015
Underlying Cryptococcal Diseases and the Correlation With Serum Cryptococcal Antigen Titers in Hospitalized HIV-Infected Patients Screened Positive for Cryptococcal AntigenemiaXu, Miaomiao; Peng, Zhihang; Xu, Chuanjun; Chen, Yaling; Cheng, Jian; Chi, Yun; Wei, Hongxia; Chen, Wei; Hu, Zhiliang · Frontiers in Cellular and Infection Microbiology · 2020
The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infectionNelson, Mark R.; Fisher, Martin; Cartledge, Jonathan; Rogers, Tom; Gazzard, Brian G. · AIDS · 1994
Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal diseaseNascimento, Erika; Vitali, Lucia Helena; Kress, Marcia Regina von Zeska; Martinez, Roberto · Revista do Instituto de Medicina Tropical de São Paulo · 2017
New therapeutic options for hepatitis CWaters, Laura; Nelson, Mark · Current Opinion in Infectious Diseases · 2006
Drug combinations for HIV: what’s new?Scourfield, Andrew; Waters, Laura; Nelson, Mark · Expert Review of Anti-infective Therapy · 2011
8th International Congress on Drug Therapy in HIV InfectionWaters, Laura; Nelson, Mark · Future Virology · 2007
The use of caspofungin in HIV-infected individualsWaters, Laura; Nelson, Mark · Expert Opinion on Investigational Drugs · 2007
A comparison of patientsʼ attitudes to antiretroviral toxicities between the UK and UgandaNelson, Mark; Mackenzie, Strachan; Yau, Stuart; Bower, Mark; Waters, Laura; Stebbing, Justin · AIDS · 2011
The value of screening HIV-infected individuals for didanosine-related liver disease?Scourfield, Andrew; Jackson, Akil; Waters, Laura; Gazzard, Brian; Nelson, Mark · 2011
Discontinuation of Atripla as first-line therapy in HIV-1 infected individualsScourfield, Andrew; Zheng, Jiexin; Chinthapalli, Suchitra; Waters, Laura; Martin, Thomas; Mandalia, Sundhiya; Nelson, Mark · AIDS · 2012
Gemcitabine in bladder cancerKarak, Fadi El; Flechon, Aude · Expert Opinion on Pharmacotherapy · 2007
New therapeutic options for onychomycosisGupta, Aditya K; Simpson, Fiona C · Expert Opinion on Pharmacotherapy · 2012
A review of olanzapine pamoateChue, Pierre; Chue, James · Expert Opinion on Pharmacotherapy · 2012
Ceftazidime for respiratory infectionsChoi, Sang-Ho; Koh, Younsuck · Expert Opinion on Pharmacotherapy · 2012
Pharmacoeconomics of asthma treatmentCleland, Jennifer; Thomas, Mike; Price, David · Expert Opinion on Pharmacotherapy · 2003
Treatment strategies in urticariaKröpfl, Lucija; Maurer, Marcus; Zuberbier, Torsten · Expert Opinion on Pharmacotherapy · 2010
Current pharmacotherapy options for gastritisden Hollander, Wouter J; Kuipers, Ernst J · Expert Opinion on Pharmacotherapy · 2012
Iloperidone for schizophreniaRado, Jeffrey; Janicak, Philip G · Expert Opinion on Pharmacotherapy · 2010